Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Perspectives of Prostate Cancer Patients on Gleason Scores and the New Grade Groups: Initial Qualitative Study.
Loeb S, Curnyn C, Sedlander E. Loeb S, et al. Among authors: sedlander e. Eur Urol. 2016 Dec;70(6):1083-1085. doi: 10.1016/j.eururo.2016.05.039. Epub 2016 Jun 7. Eur Urol. 2016. PMID: 27283215 Free PMC article. No abstract available.
Informational needs during active surveillance for prostate cancer: A qualitative study.
Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Ciprut S, Sedlander E. Loeb S, et al. Among authors: sedlander e. Patient Educ Couns. 2018 Feb;101(2):241-247. doi: 10.1016/j.pec.2017.08.022. Epub 2017 Sep 1. Patient Educ Couns. 2018. PMID: 28886974 Free PMC article.
Qualitative study on decision-making by prostate cancer physicians during active surveillance.
Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Sedlander E. Loeb S, et al. Among authors: sedlander e. BJU Int. 2017 Jul;120(1):32-39. doi: 10.1111/bju.13651. Epub 2016 Oct 2. BJU Int. 2017. PMID: 27611479 Free PMC article.
A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.
Makarov DV, Sedlander E, Braithwaite RS, Sherman SE, Zeliadt S, Gross CP, Curnyn C, Shedlin M. Makarov DV, et al. Among authors: sedlander e. Implement Sci. 2016 Sep 2;11(1):118. doi: 10.1186/s13012-016-0484-5. Implement Sci. 2016. PMID: 27590603 Free PMC article.
Health state utilities among contemporary prostate cancer patients on active surveillance.
Loeb S, Curnyn C, Walter D, Fagerlin A, Siebert U, Mühlberger N, Braithwaite RS, Schwartz MD, Lepor H, Sedlander E. Loeb S, et al. Among authors: sedlander e. Transl Androl Urol. 2018 Apr;7(2):197-202. doi: 10.21037/tau.2017.03.80. Transl Androl Urol. 2018. PMID: 29732277 Free PMC article.
Designing a theory-based intervention to improve the guideline-concordant use of imaging to stage incident prostate cancer.
Ciprut S, Sedlander E, Watts KL, Matulewicz RS, Stange KC, Sherman SE, Makarov DV. Ciprut S, et al. Among authors: sedlander e. Urol Oncol. 2018 May;36(5):246-251. doi: 10.1016/j.urolonc.2017.12.019. Epub 2018 Feb 15. Urol Oncol. 2018. PMID: 29398250 Review.
Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff.
McNeely J, Kumar PC, Rieckmann T, Sedlander E, Farkas S, Chollak C, Kannry JL, Vega A, Waite EA, Peccoralo LA, Rosenthal RN, McCarty D, Rotrosen J. McNeely J, et al. Among authors: sedlander e. Addict Sci Clin Pract. 2018 Apr 9;13(1):8. doi: 10.1186/s13722-018-0110-8. Addict Sci Clin Pract. 2018. PMID: 29628018 Free PMC article.
The RANI Project: A socio-normative intervention to reduce anemia in Odisha, India: A formative research protocol.
Sedlander E, Rimal RN, Talegawkar SA, Yilma H, Munar W. Sedlander E, et al. Gates Open Res. 2018 May 10;2:15. doi: 10.12688/gatesopenres.12808.2. eCollection 2018. Gates Open Res. 2018. PMID: 29683135 Free PMC article.
Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer.
Drangsholt S, Walter D, Ciprut S, Lepor A, Sedlander E, Curnyn C, Loeb S, Malloy P, Winn AN, Makarov DV. Drangsholt S, et al. Among authors: sedlander e. Urol Oncol. 2019 Feb;37(2):145-149. doi: 10.1016/j.urolonc.2018.11.022. Epub 2018 Dec 18. Urol Oncol. 2019. PMID: 30578160
Veterans' Preferences for Remote Management of Chronic Conditions.
Sedlander E, Barboza KC, Jensen A, Skursky N, Bennett K, Sherman S, Schwartz M. Sedlander E, et al. Telemed J E Health. 2018 Mar;24(3):229-235. doi: 10.1089/tmj.2017.0010. Epub 2017 Jul 26. Telemed J E Health. 2018. PMID: 28745941 Clinical Trial.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback